116 related articles for article (PubMed ID: 38030167)
1. PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53
Lin HW; Shih TW; Amanna A; Chang MS
Anticancer Res; 2023 Dec; 43(12):5437-5446. PubMed ID: 38030167
[TBL] [Abstract][Full Text] [Related]
2. PHRF1 promotes migration and invasion by modulating ZEB1 expression.
Lee JY; Fan CC; Chou NL; Lin HW; Chang MS
PLoS One; 2020; 15(7):e0236876. PubMed ID: 32730336
[TBL] [Abstract][Full Text] [Related]
3. ZFAS1 Promotes Colorectal Cancer Metastasis Through Modulating miR-34b/SOX4 Targeting.
Deng H; Wang M; Xu Q; Yao H
Cell Biochem Biophys; 2021 Jun; 79(2):387-396. PubMed ID: 33725330
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.
Li D; He C; Wang J; Wang Y; Bu J; Kong X; Sun D
Oncol Res; 2018 Apr; 26(3):385-400. PubMed ID: 28653608
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.
Chen Z; Zhong T; Zhong J; Tang Y; Ling B; Wang L
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760159
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of SOX4 is associated with colorectal cancer progression.
Wang B; Li Y; Tan F; Xiao Z
Tumour Biol; 2016 Jul; 37(7):9131-7. PubMed ID: 26768610
[TBL] [Abstract][Full Text] [Related]
7. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Medicine (Baltimore); 2021 Mar; 100(12):e25028. PubMed ID: 33761659
[TBL] [Abstract][Full Text] [Related]
9. SOX4 induces cytoskeleton remodeling and promotes cell motility via N-wasp/ARP2/3 pathway in colorectal cancer cells.
S A; Parida N; Patnaik S
Exp Cell Res; 2024 Jun; 439(1):114059. PubMed ID: 38705228
[TBL] [Abstract][Full Text] [Related]
10. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
[TBL] [Abstract][Full Text] [Related]
11. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
[TBL] [Abstract][Full Text] [Related]
12. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
13. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.
Wang L; Zhang J; Yang X; Chang YW; Qi M; Zhou Z; Zhang J; Han B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):301-7. PubMed ID: 23917306
[TBL] [Abstract][Full Text] [Related]
14. The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism.
Bin C; Xiaofeng H; Wanzi X
Exp Lung Res; 2018 Aug; 44(6):280-287. PubMed ID: 30475081
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
Ruan H; Yang H; Wei H; Xiao W; Lou N; Qiu B; Xu G; Song Z; Xiao H; Liu L; Zhou Y; Hu W; Chen K; Chen X; Zhang X
Int J Oncol; 2017 Jul; 51(1):336-346. PubMed ID: 28534986
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4.
Mou TY; Zhang RR; Wang YN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10751-10760. PubMed ID: 31858542
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
Li Y; Tao C; Dai L; Cui C; Chen C; Wu H; Wei Q; Zhou X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563928
[TBL] [Abstract][Full Text] [Related]
18. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
[TBL] [Abstract][Full Text] [Related]
19. Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivation.
Ettahar A; Ferrigno O; Zhang MZ; Ohnishi M; Ferrand N; Prunier C; Levy L; Bourgeade MF; Bieche I; Romero DG; Colland F; Atfi A
Cell Rep; 2013 Aug; 4(3):530-41. PubMed ID: 23911286
[TBL] [Abstract][Full Text] [Related]
20. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
